Home/Contractors/Emergent Product Development Gaithersburg INC.

Federal Contractor Profile

Emergent Product Development Gaithersburg INC.

Federal contracting record: $2.4B obligated across 15 awards from 2 agencies, FY 2016–2026.

$2.4B
Total Obligated
15
Award Records
2
Agencies Served
6
NAICS Codes
OverviewContractsAgenciesNAICS

Company Profile

UEI (Unique Entity Identifier)

CNPVCR8DK7M8

CAGE Code

057Y1

Parent Organization

Emergent Biosolutions INC.

Address

300 PROFESSIONAL DR, GAITHERSBURG, MD, 208793419

First Federal Award

Oct 30, 2015

Most Recent Award

Feb 5, 2026

Federal Sales Analytics

Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.

Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).

Top Federal Agencies

  • Department of Health and Human Services

    13 awards · 99.4% of total

    $2.4B

  • Department of Defense

    2 awards · 0.6% of total

    $15M

Top NAICS Activity

  • 541711

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY

    7 awards

    $1.5B

  • 325414

    BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING

    3 awards

    $820M

  • 541714

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

    1 awards

    $119M

  • 541712

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)

    2 awards

    $22M

  • 541715

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

    1 awards

    $5.7M

  • 541710

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES

    1 awards

    $749K

Recent Federal Awards

DateAgencyNAICSDescriptionAmount
Sep 5, 2025Department of Health and Human ServicesASPR/ORM-SNS325414ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)$56M
Aug 29, 2025Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541711IGF::OT::IGF$30M
Jan 10, 2025Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN$17M
Dec 12, 2024Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541711IGF::OT::IGF$50M
Aug 30, 2024Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN$42M
Jun 28, 2024Department of Health and Human ServicesASPR/ORM-SNS325414ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)$100M
Jun 26, 2024Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541711IGF::OT::IGF$30M
Nov 21, 2023Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541711IGF::OT::IGF$75M
Jul 31, 2023Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541714MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN$60M
Jun 16, 2023Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541711IGF::OT::IGF$75M
May 19, 2023Department of Health and Human ServicesASPR/ORM-SNS325414ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)$120M
Mar 30, 2023Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541711IGF::OT::IGF$4.5M
Mar 13, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541712IGF::OT::IGF DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS$476K
Oct 27, 2022Department of DefenseARMY MED RES ACQ ACTIVITY541715CREATION OF AN FDA APPROVED ANALGESIC KETAMINE DRUG WITH AUTO INJECTOR DELIVERY SYSTEM.$6.8M
Aug 24, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541711IGF::OT::IGF - ADVANCING STABILIZED ISOAMYL NITRITE FOR INTRANASAL TREATMENT OF CYANIDE EXPOSURE$6.8M
Jul 1, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541711TAS::75 0140::TAS ADVANCED DEVELOPMENT OF RECOMBINANT PROTECTIVE ANTIGENT (RPA) ANTHRAX VACCINE CAN 1990087$8.0M
May 19, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541712IGF::OT::IGF DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS$69K
Sep 30, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541711IGF::OT::IGF$399M
Jul 5, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)$182M
Jun 10, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541710BIOMEDICAL (BASIC)$749K
Jun 10, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541711NEW AWARD UNDER BAA NIH-NIAID-DMID-08-20. THIS IS ONE OF FOUR AWARDS UNDER THIS BAA.$1.4M
Jun 8, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541712BIOMEDICAL (ADVANCED)$2.6M
Apr 28, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414ACAMBIS, 200-2008-24959$2.8M
Mar 24, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA325414ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)$753K
Mar 18, 2021Department of DefenseW4PZ USA MED RSCH ACQUIS ACT541715CREATION OF AN FDA APPROVED ANALGESIC KETAMINE DRUG WITH AUTO INJECTOR DELIVERY SYSTEM.$4.4M

Related Contractors

Other companies active in NAICS 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY.

Alliance For Energy Innovation, LLC

$3.7B

Battelle National Biodefense Institute, LLC

$170M

Hoffmann-la Roche INC.

$62M

Cerus Corporation

$37M

Merck Sharp & Dohme LLC

$33M

Glaxosmithkline, LLC

$23M

The Emmes Company, LLC

$21M

American Type Culture Collection

$11M

Track Emergent Product Development Gaithersburg INC. Recompetes Before They Post

Mindy monitors Emergent Product Development Gaithersburg INC.'s active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.

Get Free Recompete Alerts